During the 1990's, scientific advances in understanding the mechanisms and pathophysiology of acute central nervous system injury were offset by a history of disappointing results from Phase III clinical trials of novel neuroprotective drugs.
A key property of neural processing in higher mammals is the ability to focus resources by selectively directing attention to relevant perceptions, thoughts or actions.